Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
23.01
-0.64 (-2.71%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Nurix Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $25 | Hold | Maintains | $25 | +8.65% | Sep 1, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $33 → $36 | Buy | Reiterates | $33 → $36 | +56.45% | Aug 10, 2026 |
| Needham | Needham | Buy Maintains $34 | Buy | Maintains | $34 | +47.76% | Aug 4, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $36 → $38 | Buy | Reiterates | $36 → $38 | +65.15% | Jul 28, 2026 |
| UBS | UBS | Buy Reiterates $23 → $31 | Buy | Reiterates | $23 → $31 | +34.72% | Jul 22, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $28 | Buy | Maintains | $28 | +21.69% | Jul 10, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $40 | Buy | Reiterates | $40 | +73.84% | Jul 10, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $32 → $34 | Buy | Reiterates | $32 → $34 | +47.76% | Jul 10, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.